Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT06083454 · TERMINATED
Trial details
- NCT number
- NCT06083454
- Sponsor
- William Zeitler
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2025-04-04
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.